Scientists have developed an experimental diabetes and obesity pill that works in a completely different way from drugs like ...

Duke biomedical engineers have developed a new way to deliver a broad range of peptide-based drugs orally that works as well ...

Studies released in recent weeks are fueling optimism — and fresh questions — about GLP-1 drugs' potential role in cancer ...

Starting July 2026, Cigna is drawing a line in the sand by discontinuing coverage for popular weight-loss medications like ...

Are your blood glucose readings inaccurate? Learn how to avoid common testing mistakes like finger squeezing and using the ...

New-generation GLP-1 drugs, such as retatrutide, are achieving higher rates of weight loss. How much weight is too much and ...

In a blog post, the company disclosed that it had begun developing a smart contact lens prototype that could measure glucose levels in tears via a miniaturized sensor nestled inside its layers. The ...

Tens of thousands of Massachusetts residents dropped health insurance coverage through the Affordable Care Act marketplace ...

A drug originally developed to treat type 2 diabetes may also help lower blood pressure, according to a study presented at a ...

A new study conducted among thousands of participants has found a daily target that may assist not only in weight loss, but also in preventing the recurrent weight regain that troubles many.

With better screening for type 1 diabetes and a new treatment called TZield, the outlook is improving for people with the autoimmune disease.

Novo Nordisk (NVO) surged 25% on Ozempic/Wegovy pill launches, FDA approvals, and low valuation. See here for more details.